AbCellera Biologics (ABCL) grants director 111,701 share options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
AbCellera Biologics Inc. director Michael R. Hayden received a grant of share options covering 111,701 common shares. The options have an exercise price of $5.27 per share, expire on June 11, 2036, and represent compensation rather than an open-market purchase.
The options vest and become exercisable at the company’s 2027 Annual General Meeting, subject to his continuous service with AbCellera through that date. Following this award, he holds options on a total of 1,011,544 underlying common shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hayden Michael R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share option (right to buy) | 111,701 | $0.00 | -- |
Holdings After Transaction:
Share option (right to buy) — 1,011,544 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 111,701 shares
Exercise price: $5.27 per share
Expiration date: June 11, 2036
+2 more
5 metrics
Options granted
111,701 shares
Share option grant to director on June 11, 2026
Exercise price
$5.27 per share
Strike price of newly granted options
Expiration date
June 11, 2036
Option term for this grant
Total options after grant
1,011,544 shares
Underlying common shares following this award
Vesting event
2027 Annual General Meeting
Options vest at 2027 AGM if service continues
Key Terms
Share option (right to buy), exercise price, expiration date, Annual General Meeting
4 terms
exercise price financial
"conversion_or_exercise_price: "5.2700" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-11T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Annual General Meeting financial
"vest and become exercisable at the 2027 Annual General Meeting"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did AbCellera (ABCL) director Michael R. Hayden report on this Form 4?
Director Michael R. Hayden reported receiving a grant of share options for 111,701 AbCellera common shares. This is a compensation-related award, not an open-market trade, and increases his directly held option-based exposure to the company’s stock.
When do Michael R. Hayden’s newly granted AbCellera options vest?
The options vest and become exercisable at AbCellera’s 2027 Annual General Meeting. Vesting is conditioned on Hayden’s continuous service to the company through that date, aligning the award with his ongoing board role.
Does this AbCellera Form 4 show any stock sales or purchases by Michael R. Hayden?
The Form 4 shows no stock sales or open-market purchases by Hayden. It reports only a grant of share options as compensation, classified as a derivative acquisition rather than a buy or sell transaction in the company’s common shares.